Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36 N.5, and our video podcast, CANCER BUZZ TV.
Biomarkers: A Roadmap for Personalized Lung Cancer Care, Live Panel, November 1 7pm ET



In This Section

Home / Learn / Precision Medicine

Precision Medicine

Precision medicine (also known as personalized medicine) uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat cancer. Precision medicine includes the use of biomarkers, molecular testing, and targeted therapies to deliver a personalized approach to cancer therapy through the use of molecular and genomic information about individual cancers. The National Cancer Institute (NCI) defines precision medicine as “discovering unique therapies that treat an individual’s cancer based on the specific abnormalities of their tumor.”

Featured Opportunity

Optimizing Advanced NSCLC Biomarker Testing, Treatment, and Management
ACCC—in partnership with the American Society for Clinical Pathology—is committed to providing the resources, tools, and education you need to optimize the diagnosis, testing, and management of patients with advanced NSCLC—particularly those with ALK mutations. Receive up to 4.5 hours of CME/CMLE credit as you increase your knowledge in the testing, treatment, and management of patients with advanced NSCLC.

Upcoming Webinars and Events

On-Demand Webinars

Cancer Buzz Podcast

  • [VIDEO PODCAST] Ep 07: Genetic Testing & Telehealth
    Oct 21, 2021

    Genetic counselors—as members of the cancer care team—can help patients better understand their cancer diagnosis, make informed treatment decisions, and navigate the financial costs of testing.

  • [PODCAST] Ep 55: What You Need to Know about Liquid Biopsy
    Mar 30, 2021

    Learn about the current clinical applications of liquid biopsies, associated reimbursement issues, and what you can do to implement these tests at your program.

  • [PODCAST] Ep 53: Telehealth & Genetics During COVID-19
    Feb 23, 2021

    Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.

  • [PODCAST] Ep 44: The Promise of Bispecific Antibodies
    Nov 24, 2020

    Learn about the latest promising breakthroughs in immunotherapy, the challenges facing their widespread use, and what your cancer team needs to know about the future of cancer treatment.

    Chaer-Firas-100x100-circleFiras El Chaer, MD, Assistant Professor of Medicine, Department of Hematology and Oncology,
    University of Virginia, Emily Couric Clinical Cancer Center

From Oncology Issues

Digital tools

Biomarker Lexicon
Explore the many terms associated with the different areas and applications of cancer biomarkers.

Biomarker Resource Library
Search this resource bank of nationally available materials relevant to cancer biomarkers and biomarker testing. You may filter by cancer type, area of application, and/or primary audience.

Biomarker Toolkit
This practical toolkit is centered around the four key elements needed to develop a precision medicine program that successfully incorporates biomarker testing.

MRD Testing Implementation Roadmap
Navigate how to lay the groundwork for MRD testing, prepare your care team, implement testing, and evaluate ongoing progress.

MRD Testing Resource Library
Curated materials to help establish and implement MRD testing for your patients with adult B-cell ALL.

Biomarker Testing Implementation Roadmap for Advanced NSCLC
An innovative tool to implement, expand, and sustain biomarker testing for patients with advanced NSCLC.

Biomarker Testing Resource Library
Curated materials to support the implementation of biomarker testing for patients with advanced NSCLC.

Bispecific Antibodies Resources
Links to recent scholarship and resources that can help practices better serve their patients who may be eligible for TRBA therapy.